Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication: A pilot study on marker lesion

European Urology

Volumn 39, Issue 1, 2001, Pages 95-100

  Colombo, Renzo ^a   Brausi, M ^a   Da Pozzo, L F ^a   Salonia, A ^a   Montorsi, F ^a   Scattoni, V ^a   Roscigno, M ^a   Rigatti, P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bladder cancer; Iontophoresis; Local hyperthermia

Indexed keywords

MITOMYCIN C;

ARTICLE; BLADDER CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DYSURIA; HEMATURIA; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; NOCTURIA; PELVIS PAIN SYNDROME; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; HUMANS; HYPERTHERMIA, INDUCED; IONTOPHORESIS; MITOMYCIN; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0035135911     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052419     Document Type: Article

References (28)

1. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: Influence on recurrence, progression and survival
2. Long-term results of intravesical therapy for superficial bladder cancer
3. Adjuvant intravesical pharmacotherapy for superficial bladder cancer
4. The management of superficial bladder cancer
5. Intravesical chemotherapy: Treatment selection techniques and results
6. Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions)
7. Superficial bladder cancer progression and recurrence
8. Neoadjuvant combined microwave-induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer
9. Electromotive drug administration to the urinary bladder: An animal model and preliminary results
10. Intravesical electromotive drug administration technique: Preliminary results and side effects
11. Role of intravesical mitomycin C in management of superficial bladder tumors
12. Mitomycin C bladder instillation therapy for bladder tumors
13. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies
14. Hyperthermia and drugs
15. The clinical efficacy of localized hyperthermia
16. Hyperthermia in the treatment of bladder tumours
17. Hyperthermic perfusion of the distended urinary bladder in the management of recurrent transitional cell carcinoma
18. Hyperthermic perfusion of the distended bladder in the management of recurrent transitional cell carcinoma: A review of 6 years
19. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C
20. Preoperative hyperthermo-chemo-radiotherapy effective for carcinoma of the esophagus
21. Combination of hyperthermia and cytostatics in the treatment of bladder cancer
22. Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hypertheramia as a preoperative therapy for superficial bladder tumors: A preliminary clinical study
23. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment
24. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors
25. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis
26. Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsicin
27. Electromotive delivery of mitomycin C into human bladder wall
28. Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: A comparative phase II study